{"title":"Rituximab","summary":"Rituximab, sold under the brand name Rituxan, is a medication used to treat certain autoimmune diseases and types of cancer.[9] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in non-geriatric patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epsteinâ€“Barr virus-positive mucocutaneous ulcers.[9][10][11][12] It is given by slow injection into a vein.[9] Biosimilars of Rituxan include Blitzima, Riabni, Ritemvia, Rituenza (F.K.A. Tuxella), Rixathon, Ruxience, and Truxima.[13][14]","image":"Rituximab.png.webp"}